List of Provigil drug patents
Provigil is owned by Cephalon.
Provigil contains Modafinil.
Provigil has a total of 2 drug patents out of which 0 drug patents have expired.
Provigil was authorised for market use on 24 December, 1998.
Provigil is available in tablet;oral dosage forms.
The generics of Provigil are possible to be released after 29 May, 2024.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7297346 | CEPHALON | Pharmaceutical formulations of modafinil |
Nov, 2023
(10 months from now) | |
|
US7297346
(Pediatric) | CEPHALON | Pharmaceutical formulations of modafinil |
May, 2024
(1 year, 4 months from now) | |
Drugs and Companies using MODAFINIL ingredient
Market Authorisation Date: 24 December, 1998
Treatment: NA
Dosage: TABLET;ORAL
How can I launch a generic of PROVIGIL before it's patent expiration?
More Information on Dosage
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic